ANNX
Annexon IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$975.04M
P/E Ratio
—
EPS
$-1.34
Beta
1.15
52W High
$7.18
52W Low
$1.60
50-Day MA
$5.60
200-Day MA
$4.20
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Annexon Inc
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for autoimmune and neurodegenerative diseases. The company is headquartered in South San Francisco, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-214.24M |
| Operating Margin | 0.00% |
| Return on Equity | -81.90% |
| Return on Assets | -43.10% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.42 |
| Price-to-Book | 4.63 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -2.47 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $162.51M |
| Float | $131.09M |
| % Insiders | 0.40% |
| % Institutions | 93.34% |
Historical Volatility
HV 10-Day
41.48%
HV 20-Day
55.30%
HV 30-Day
70.58%
HV 60-Day
70.22%
HV Rank
17.1%
Volatility is currently contracting
Analyst Ratings
Consensus ($13.71 target)
2
Strong Buy7
BuyData last updated: 4/29/2026